2001
Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study
Vermund SH. Vaccine Efficacy Trials for Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Are Feasible in the United States: A Commentary on the HIVNET Vaccine Preparedness Study. American Journal Of Epidemiology 2001, 153: 628-631. PMID: 11282788, DOI: 10.1093/aje/153.7.628.Peer-Reviewed Original Research
1994
Prevention of HIV/AIDS with vaccines
Vermund S, Schultz A, Hoff R. Prevention of HIV/AIDS with vaccines. Current Opinion In Infectious Diseases 1994, 7: 82-94. DOI: 10.1097/00001432-199402000-00014.Peer-Reviewed Original ResearchHIV vaccineVaccine preparedness studyPhase II trialPhase III trialsHigh-risk populationHuman phase IViral envelope antigensHIV vaccine efficacyHigh behavioral riskLife-long infectionHIV/AIDSRecombinant subunit vaccinesEnvelope vaccinesHIV vaccinationII trialIII trialsClinical updateVaccine efficacyPreventive counselingEffective vaccineEfficacy trialsEnvelope antigenFirst vaccineTrial participantsLive vector